Phase II trial of subcutaneous PL 3994 for the treatment of acute decompensated heart failure.

Trial Profile

Phase II trial of subcutaneous PL 3994 for the treatment of acute decompensated heart failure.

Planning
Phase of Trial: Phase II

Latest Information Update: 28 Sep 2015

At a glance

  • Drugs PL 3994 (Primary)
  • Indications Decompensated heart failure
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Palatin Technologies
  • Most Recent Events

    • 28 Sep 2015 Planned initiation date changed from 1 Jun 2015 to 1 Jan 2016, as per Palatin media release.
    • 11 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top